Arman Sabet on Muck Rack

Arman Sabet

As seen in: The Lancet, Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Arman

Contact Arman, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Expert Consensus on Vitamin B6 Therapeutic Use for Patients: Guidance | DHPS

|
By Natalie Schellack, Kitiyot Yotsombut, Arman Sabet, Jalal Nafach
| Dove Medical Press
Back to Journals » Drug, Healthcare and Patient Safety » Volume 17 Authors Schellack N, Yotsombut K , Sabet A, Nafach J, Hiew FL, Kulkantrakorn K Received 15 October 2024 Accepted for publication 26 March 2025 Published 7 April 2025 Volume 2025:17 Pages 97—108 DOI https://doi.org/10.2147/DHPS.S499941 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Siew Siang Chua Natalie Schellack,1 Kitiyot Yotsombut,2 Arman...
Open in Who Shared Issue with article?

Intravenous versus subcutaneous immunoglobulin - Authors' reply

|
By Orell Mielke, Arman Sabet, Koshy George
| The Lancet Verified
We thank Ravi Uniyal and colleagues for their comments on our results from the PATH trial1x1van Schaik, IN, Bril, V, van Geloven, N et al. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol.
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified